Literature DB >> 21116280

Deletions of Xp22.2 including PIG-A locus lead to paroxysmal nocturnal hemoglobinuria.

C L O'Keefe, C Sugimori, M Afable, M Clemente, K Shain, D J Araten, A List, P K Epling-Burnette, J P Maciejewski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21116280     DOI： 10.1038/leu.2010.274

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   12.883


× No keyword cloud information.
  10 in total

1.  SF3B1 mutations are infrequently found in non-myelodysplastic bone marrow failure syndromes and mast cell diseases but, if present, are associated with the ring sideroblast phenotype.

Authors:  Valeria Visconte; Ali Tabarroki; Heesun J Rogers; Edy Hasrouni; Fabiola Traina; Hideki Makishima; Betty K Hamilton; Yang Liu; Christine O'Keefe; Alan Lichtin; Leonard Horwitz; Mikkael A Sekeres; Fred H Hsieh; Ramon V Tiu
Journal:  Haematologica       Date:  2013-07-05       Impact factor: 9.941

2.  The rate of spontaneous mutations in human myeloid cells.

Authors:  David J Araten; Ondrej Krejci; Kimberly Ditata; Mark Wunderlich; Katie J Sanders; Leah Zamechek; James C Mulloy
Journal:  Mutat Res       Date:  2013-06-06       Impact factor: 2.433

3.  Deep sequencing reveals stepwise mutation acquisition in paroxysmal nocturnal hemoglobinuria.

Authors:  Wenyi Shen; Michael J Clemente; Naoko Hosono; Kenichi Yoshida; Bartlomiej Przychodzen; Tetsuichi Yoshizato; Yuichi Shiraishi; Satoru Miyano; Seishi Ogawa; Jaroslaw P Maciejewski; Hideki Makishima
Journal:  J Clin Invest       Date:  2014-09-17       Impact factor: 14.808

4.  The mutational landscape of paroxysmal nocturnal hemoglobinuria revealed: new insights into clonal dominance.

Authors:  Stanley Chun-Wei Lee; Omar Abdel-Wahab
Journal:  J Clin Invest       Date:  2014-09-17       Impact factor: 14.808

5.  Leukemic blasts with the paroxysmal nocturnal hemoglobinuria phenotype in children with acute lymphoblastic leukemia.

Authors:  David J Araten; Katie J Sanders; Dan Anscher; Leah Zamechek; Stephen P Hunger; Sherif Ibrahim
Journal:  Am J Pathol       Date:  2012-08-30       Impact factor: 4.307

6.  Clonal PIGA mosaicism and dynamics in paroxysmal nocturnal hemoglobinuria.

Authors:  Michael J Clemente; Bartlomiej Przychodzen; Cassandra M Hirsch; Yasunobu Nagata; Taha Bat; Marcin W Wlodarski; Tomas Radivoyevitch; Hideki Makishima; Jaroslaw P Maciejewski
Journal:  Leukemia       Date:  2018-04-25       Impact factor: 11.528

7.  Paroxysmal nocturnal hemoglobinuria and concurrent JAK2(V617F) mutation.

Authors:  C Sugimori; E Padron; G Caceres; K Shain; L Sokol; L Zhang; R Tiu; C L O'Keefe; M Afable; M Clemente; J M Lee; J P Maciejewski; A F List; P K Epling-Burnette; D J Araten
Journal:  Blood Cancer J       Date:  2012-03-23       Impact factor: 11.037

8.  Implication of PIGA genotype on erythrocytes phenotype in Paroxysmal Nocturnal Hemoglobinuria.

Authors:  Carmelo Gurnari; Simona Pagliuca; Bhumika J Patel; Hassan Awada; Sunisa Kongkiatkamon; Laila Terkawi; Misam Zawit; Seth Corey; Alan E Lichtin; Hetty E Carraway; Adam Wahida; Valeria Visconte; Jaroslaw P Maciejewski
Journal:  Leukemia       Date:  2021-01-22       Impact factor: 12.883

9.  Application of counter-selectable marker PIGA in engineering designer deletion cell lines and characterization of CRISPR deletion efficiency.

Authors:  Donghui Li; Xiaoji Sun; Fangzhou Yu; Mary Ann Perle; David Araten; Jef D Boeke
Journal:  Nucleic Acids Res       Date:  2021-03-18       Impact factor: 16.971

10.  Development of paroxysmal nocturnal hemoglobinuria in CALR-positive myeloproliferative neoplasm.

Authors:  Yarden S Fraiman; Nathan Cuka; Denise Batista; Milena Vuica-Ross; Alison R Moliterno
Journal:  J Blood Med       Date:  2016-05-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.